Skip to main content
Clinical Trials/JPRN-jRCT1080220055
JPRN-jRCT1080220055
Unknown
Phase 3

A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC).

Taiho Pharmaceutical Co., Ltd.0 sitesSeptember 7, 2005
ConditionsBreast caner

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Breast caner
Sponsor
Taiho Pharmaceutical Co., Ltd.
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 7, 2005
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with Stage I, II or IIIA high\-risk breast cancer negative for lymph node metastasis.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials